Articles in the Bulletin have been unsigned since it began. This is because they aim to present a consensus view which incorporates contributions from many people, including specialists, general practitioners and members of the pharmaceutical industry, as well as the Bulletin’s Advisory Council. We are very grateful to them all, but although we have often been asked who they are, we cannot name the many hundreds who have helped us in any one year. However, we can at least name those not listed in our tailpiece who have taken a major share in the production of articles published in the last three years, and do so now. We also warmly thank Airlie Ogilvy, our production editor who retired recently after keeping the Bulletin going for 24 years.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.